deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT05413161

To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects

A Randomized, Double Blind, Three-arm, Parallel Group, Single Dose Comparative PK, PD, Safety and Immunogenicity Study Comparing ADL-018 With US-licensed XOLAIR and EU-Approved XOLAIR in Healthy Adult Subjects

Sponsor: Kashiv BioSciences, LLC

Conditions Healthy
Interventions ADL-018 EU-Approved XOLAIR US-licensed XOLAIR
Updated 9 times since 2022 Last updated: Jun 30, 2023 Started: Jul 7, 2022 Primary completion: Feb 21, 2023 Completion: Jun 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Kashiv BioSciences, LLC leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2022 – ~Oct 2022 · 30 days · monthly snapshotRecruiting~Oct 2022 – ~Apr 2023 · 6 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2023 · 3 months · monthly snapshotRecruiting~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshotRecruiting~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Aug 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  5. Jul 2023 — Aug 2023 [monthly]

    Recruiting PHASE1

▶ Show 4 earlier versions

  1. Apr 2023 — Jul 2023 [monthly]

    Recruiting PHASE1

  2. Oct 2022 — Apr 2023 [monthly]

    Recruiting PHASE1

  3. Sep 2022 — Oct 2022 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  4. Jul 2022 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kashiv BioSciences, LLC
Data source: Kashiv BioSciences, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations